DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

Dow Jones

2025/02/15

By Katherine Hamilton

DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company.

The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year.

Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been.

Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder.

DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level.

Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

February 14, 2025 14:35 ET (19:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2511611920"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2511611920\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2511611920?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-15 03:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2511611920","market":"sg","top_or_hot":-1,"title":"DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. \n</p>\n<p>\n  The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year. \n</p>\n<p>\n  Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been. \n</p>\n<p>\n  Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder. \n</p>\n<p>\n  DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level. \n</p>\n<p>\n  Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 14, 2025 14:35 ET (19:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-15 03:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. \n</p>\n<p>\n  The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year. \n</p>\n<p>\n  Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been. \n</p>\n<p>\n  Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder. \n</p>\n<p>\n  DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level. \n</p>\n<p>\n  Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 14, 2025 14:35 ET (19:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2511611920","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2511611920","pubTimestamp":1739561700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company.The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year.Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been.Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder.DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level.Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company gu","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健","BRK.B":"伯克希尔B","BRK.A":"伯克希尔"},"translate_title":"伯克希尔哈撒韦公司出售前景未达预期后，DaVita股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":0.9,"BRK.A":1,"BRK.B":1},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. \n\n\n  The stock declined 10% to $158.96 on Friday, though it is up about 30% over the past year. \n\n\n  Berkshire's sale of the shares has been in the works for months, but came on the heels of DaVita's fourth-quarter earnings. They showed the company is less optimistic about 2025 earnings than Wall Street has been. \n\n\n  Berkshire Chairman Warren Buffett sold 203,091 shares at $156.01 a share, offloading a total of $31.7 million, according to a Thursday filing with the Securities and Exchange Commission. Berkshire still has 35.9 million shares, making it the kidney dialysis company's largest stakeholder. \n\n\n  DaVita said in May it would buy back stock from Berkshire when its ownership surpassed 45%. Berkshire's sale this week brings its stake back down to that level. \n\n\n  Shares of DaVita began falling Thursday night before Berkshire's sale became public. After the bell, the healthcare company guided for adjusted earnings of $10.20 to $11.30 in 2025, below analysts' expectations of $11.38. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 14:35 ET (19:35 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}